Health Canada
Symbol of the Government of Canada

Common menu bar links

Drugs and Health Products

Market Data

Based on market data, there is overall sufficient supply of marijuana for medical purposes to meet the current access needs of registered clients. Please note that amounts produced do not reflect the full production capacity authorized to licensed producers.

Market Data: Marijuana for Medical Purposes
  April 1, 2015 to June 30, 2015 (Q1) July 1, 2015 to September 30, 2015 (Q2) October 1, 2015 to December 31, 2015 (Q3) January 1, 2016 to March 31, 2016 (Q4)

Table 1 footnotes

Table 1 footnote 1

This refers to the amount of dried marijuana produced that was tested, approved, and ready for sale during each quarter (expressed in kg of dried marijuana).

Return to table 1 footnote 1 referrer

Table 1 footnote 2

Changes in inventories may be a result of amounts of dried marijuana sold, produced, destroyed and imported.

Inventory refers to all dried marijuana held in stock at the end of each quarter. This may include dried marijuana that: (1) has been dried, but not tested; (2) has been dried and tested, but not approved; or (3) is ready for sale (has been dried, tested, approved, packaged and labelled). Companies may only keep inventory up to the maximum capacity allowed by their licence. Any company holding excess material will face immediate compliance and enforcement action.

Return to table 1 footnote 2 referrer

Table 1 footnote 3

There were sales of cannabis oil in Q3 by only one licensed producer. As the data is not aggregate sales from multiple licensed producers, the specific amount of cannabis oil sold is being withheld because it is considered confidential business information.

Return to table 1 footnote 3 referrer

Table 1 footnote 4

This refers to the amount of cannabis oil produced that was tested, approved, and ready for sale during each quarter (expressed in kg of cannabis oil).

Return to table 1 footnote 4 referrer

Table 1 footnote 5

Changes in inventories may be a result of amounts of cannabis oil sold, produced, and destroyed.

Inventory refers to all cannabis oil held in stock at the end of each quarter. This may include cannabis oil that: (1) has not been tested; (2) has been tested, but not approved; or (3) is ready for sale (has been tested, approved, packaged and labelled). Companies may only keep inventory up to the maximum capacity allowed by their licence. Any company holding excess material will face immediate compliance and enforcement action.

Return to table 1 footnote 5 referrer

Table 1 footnote 6

The Marihuana for Medical Purposes Regulations require that health care practitioners include the daily quantity of dried marijuana, expressed in grams, on all medical documents used to register a client. It is the responsibility of each licensed producer to determine the quantity of cannabis oil that is equivalent to one gram of dried marijuana (“the equivalency factor”). Information about the equivalency factor is available on each licensed producer’s website.

Return to table 1 footnote 6 referrer

Dried Marijuana
Amount sold to clients (kilograms) 1,371 1,873 2,481 -
Amount produced during quarter (kilograms)Table 1 footnote 1 1,867 2,142 2,684 -
Amount in licensed producers' inventories at end of quarter (kilograms)Table 1 footnote 2 5,445 7,312 9,729 -
Cannabis Oil
Amount sold to clients (kilograms) N/A N/A N/ATable 1 footnote 3 -
Amount produced (kilograms)Table 1 footnote 4 N/A 9 128 -
Amount in licensed producers' inventories at end of quarter (kilograms)Table 1 footnote 5 N/A 7 208 -
Client Data
Average amount of dried marijuana for medical purposes authorized per client (grams/day)Table 1 footnote 6 3.3 3.0 2.9 -
Average amount of marijuana for medical purposes per client shipment (grams/day) 1.08 1.12 1.12 -
Total number of clients registered at end of quarter 23,930 30,537 39,668 -

MMPR Market Data - Dried Marijuana (2015-2016)

Graph of the data from the preceding table

Changes in inventories may be a result of amounts of dried marijuana sold, produced, destroyed and imported.

Inventory refers to all dried marijuana held in stock at the end of each quarter. This may include dried marijuana that: (1) has been dried, but not tested; (2) has been dried and tested, but not approved; or (3) is ready for sale (has been dried, tested, approved, packaged and labelled). Companies may only keep inventory up to the maximum capacity allowed by their licence. Any company holding excess material will face immediate compliance and enforcement action.

MMPR Market Data - Cannabis Oil (2015-2016)Footnote *

Graph of the data from the preceding table

Footnotes

Footnote *

Licensed producers were not authorized to produce or sell cannabis oil in Q1.

Return to footnote * referrer

Please note that changes in inventories may be a result of amounts of cannabis oil sold, produced, and destroyed.

Inventory refers to all cannabis oil held in stock at the end of each quarter. This may include cannabis oil that: (1) has not been tested; (2) has been tested, but not approved; or (3) is ready for sale (has been tested, approved, packaged and labelled). Companies may only keep inventory up to the maximum capacity allowed by their licence. Any company holding excess material will face immediate compliance and enforcement action.

2014 - 2015 Fiscal Year

Market Data: Marijuana for Medical Purposes
  April 1, 2014 to June 30, 2014 (Q1) July 1, 2014 to September 30, 2014 (Q2) October 1, 2014 to December 31, 2014 (Q3) January 1, 2015 to March 31, 2015 (Q4)

Table 2 footnotes

Table 2 footnote 1

This refers to the amount of dried marijuana produced that was tested, approved, and ready for sale during each quarter (expressed in kg of dried marijuana). The amount does not include cannabis oil.

Return to table 2 footnote 1 referrer

Table 2 footnote 2

Changes in inventories may be a result of amounts of marijuana for medical purposes sold, produced, destroyed and imported.

Inventory refers to all dried marijuana held in stock at the end of each quarter. This may include dried marijuana that: (1) has been dried, but not tested; (2) has been dried and tested, but not approved; or (3) is ready for sale (has been dried, tested, approved, packaged and labelled). Companies may only keep inventory up to the maximum capacity allowed by their licence. Any company holding excess material will face immediate compliance and enforcement action.

Return to table 2 footnote 2 referrer

Amount of dried marijuana sold to clients (kilograms) 408 596 789 979
Amount of dried marijuana produced during quarter (kilograms)Table 2 footnote 1 1,020 1,435 1,809 1,618
Amount of dried marijuana for medical purposes in licensed producers' inventories at end of quarter (kilograms)Table 2 footnote 2 1,134 2,021 2,994 4,667
Average amount of marijuana for medical purposes authorized per client (grams/day) 4 4 4 4
Average amount of marijuana for medical purposes per client shipment (grams/day) 1 1 1 1
Total number of clients registered at end of quarter 7,914 12,409 15,545 18,512

MMPR Market Data (2014-2015)

Graph of the data from the first three rows of the preceding table